Evidence map›Paper›PMID 34549367›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2021

Selected polyoxopalladates as promising and selective antitumor drug candidates.

Andjelka M Isakovic, Mirjana B Čolović, Tian Ma, Xiang Ma, Marija Jeremic, Marko Gerić, Goran Gajski, Sonja Misirlic-Dencic, Ulrich Kortz, Danijela Krstić

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Peroxo-Containing Heteropolyanions [{XWInorganic chemistry · 2026
    Article
  2. Article
  3. All-Inorganic Polyoxometalates Act as Superchaotropic Membrane Carriers.Advanced materials (Deerfield Beach, Fla.) · 2024
    Article
  4. Polyoxometalates Impact as Anticancer Agents.International journal of molecular sciences · 2023
    Review
  5. Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Andjelka M IsakovicInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID 0000-0001-5270-709X
Mirjana B ČolovićDepartment of Physical Chemistry, "Vinča" Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.ORCID 0000-0001-5037-9985
Tian MaDepartment of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.
Xiang MaDepartment of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.
Marija JeremicInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Marko GerićInstitute for Medical Research and Occupational Health, Mutagenesis Unit, Zagreb, Croatia.ORCID 0000-0002-5886-4106
Goran GajskiInstitute for Medical Research and Occupational Health, Mutagenesis Unit, Zagreb, Croatia.ORCID 0000-0002-1886-1453
Sonja Misirlic-DencicInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. sonja.misirlic-dencic@med.bg.ac.rs.ORCID 0000-0002-8635-4701
Ulrich KortzDepartment of Life Sciences and Chemistry, Jacobs University, Bremen, Germany. u.kortz@jacobs-university.de.ORCID 0000-0002-5472-3058
Danijela KrstićInstitute of Medical Chemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. danijela.krstic@med.bg.ac.rs.ORCID 0000-0002-9192-8087
University of Belgrade · RSConstructor University · DEInstitute for Medical Research and Occupational Health · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyoxo-noble-metalates (PONMs), a class of molecular noble metal-oxo nanoclusters that combine features of both polyoxometalates and noble metals, are a promising platform for the development of next-generation antitumor metallodrugs. This study aimed to evaluate the antitumor potential against human neuroblastoma cells (SH-SY5Y), as well as toxicity towards healthy human peripheral blood cells (HPBCs), of five polyoxopalladates(II): (Na

Indexed as

Antineoplastic AgentsNeuroblastomaApoptosisCell Line, TumorCell SurvivalCisplatinHumansAntineoplastic AgentsCisplatinAntitumorCytogenotoxicityHuman neuroblastoma cells (SH-SY5Y)Human peripheral blood cellsPolyoxopalladates

Identifiers

PMID34549367
OpenAlexW3199857419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.